S.C. Financial Services, Inc. Brainstorm Cell Therapeutics Inc. Transaction History
S.C. Financial Services, Inc.
- $65 Billion
- Q4 2022
A detailed history of S.C. Financial Services, Inc. transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, S.C. Financial Services, Inc. holds 12,686 shares of BCLI stock, worth $15,857. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,686
Previous 12,686
-0.0%
Holding current value
$15,857
Previous $20.8 Million
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding BCLI
# of Institutions
7Shares Held
534KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY386KShares$483,0170.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$118,9410.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA22.7KShares$28,3320.01% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ10.5KShares$13,1480.0% of portfolio
-
Institutional & Family Asset Management, LLC6KShares$7,5000.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $45.6M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...